电针治疗围绝经期综合征的系统评价与Meta分析
该系统评价纳入12项随机对照试验共746名女性,评估电针治疗围绝经期综合征的疗效与安全性。电针与激素治疗在有效率、Kupperman指数及性激素水平上无显著差异,但电针降低Kupperman指数优于假电针和手针,提示其效应超越安慰剂。证据受限于研究数量少、偏倚风险及异质性,需更多高质量大样本随机对照试验验证。
要点
- 电针与激素治疗在有效率和Kupperman指数上无显著差异。
- 电针降低Kupperman指数和潮热评分显著优于假电针。
- 电针降低Kupperman指数优于手针,但其余指标无显著差异。
核心结论
- 电针治疗围绝经期综合征的效应与激素治疗和手针大致相似。
- 电针降低Kupperman指数优于手针和假电针,提示其效应超越安慰剂。
- 证据受限于纳入研究少、偏倚风险及临床/统计异质性,无法得出确定结论。
研究设计与样本
- 系统评价与Meta分析,检索9个数据库至2019年6月。
- 纳入12项随机对照试验,共746名女性。
主要发现
- 电针与激素治疗在有效率(RR=0.98,95%CI 0.93至1.04)、Kupperman指数(MD=-0.25,95%CI -0.76至0.26)、FSH(MD=-3.80,95%CI -11.59至3.98)和LH(MD=-2.51,95%CI -10.72至5.70)上无显著差异。
- 电针组血清E2水平显著低于激素治疗组(MD=-60.58,95%CI -71.93至-49.23)。
- 与假电针相比,电针显著降低Kupperman指数(MD=-4.71,95%CI -6.57至-2.86)和每24小时潮热评分(MD=-2.43,95%CI -2.93至-1.93)。
- 电针与手针在有效率(RR=1.14,95%CI 0.98至1.33)、FSH(MD=-2.87,95%CI -29.65至23.91)、LH(MD=2.73,95%CI -9.65至15.11)和E2(MD=26.80,95%CI -12.06至65.65)上无显著差异,但电针降低Kupperman指数优于手针(MD=-2.44,95%CI -4.80至-0.08)。
- 亚组分析提示电针对绝经前状态可能更有益(每24小时潮热评分:MD=-1.66,95%CI -3.49至0.17),与绝经后相比(p>0.05)。
关键数值与推荐
- 电针与激素治疗有效率RR=0.98(95%CI 0.93至1.04)。
- 电针与假电针Kupperman指数MD=-4.71(95%CI -6.57至-2.86)。
- 电针与假电针每24小时潮热评分MD=-2.43(95%CI -2.93至-1.93)。
- 电针与手针Kupperman指数MD=-2.44(95%CI -4.80至-0.08)。
临床怎么用
- 电针可作为围绝经期综合征的替代疗法,尤其适用于关注Kupperman指数和潮热症状改善者。
- 电针在改善Kupperman指数方面可能优于手针和假电针,但其对性激素水平的影响与激素治疗存在差异,需结合患者情况选择。
- 绝经前女性可能从电针中更多获益,但证据尚不充分,临床决策需个体化。
局限性
- 纳入研究数量少,样本量有限。
- 存在偏倚风险。
- 临床和统计异质性较大,限制结论的可靠性。
- 需要更多大规模高质量随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy, comparative effectiveness and safety of electroacupuncture (EA) in the treatment of perimenopausal syndrome (PMS). METHODS: Nine databases were searched until June 2019. Only relevant randomized controlled trials (RCTs) of EA for PMS were included. RESULTS: Twelve trials involving 746 women were included. EA and hormone therapy (HT) did not significantly differ in terms of effective rate (risk ratio (RR) = 0.98, 95% confidence interval (CI) = 0.93 to 1.04), Kupperman index (KI) (mean difference (MD) = -0.25, 95% CI = -0.76 to 0.26) and serum levels of follicle-stimulating hormone (FSH) (MD = -3.80, 95% CI = -11.59 to 3.98) or luteinizing hormone (LH) (MD = -2.51, 95% CI = -10.72 to 5.70). Serum estradiol (E2) levels were significantly lower in EA versus HT groups (MD = -60.58, 95% CI = -71.93 to -49.23). Compared with sham EA, EA had a significantly greater effect on reductions in KI (MD = -4.71, 95% CI = -6.57 to -2.86) and hot flushes score/24 h (MD = -2.43, 95% CI = -2.93 to -1.93). There were no significant differences between EA and manual acupuncture (MA) in terms of effective rate (RR = 1.14, 95% CI = 0.98 to 1.33) or serum FSH (MD = -2.87, 95% CI = -29.65 to 23.91), LH (MD = 2.73, 95% CI = -9.65 to 15.11) or E2 (MD = 26.80, 95% CI = -12.06 to 65.65). However, it seemed that EA had a better effect than MA on KI (MD = -2.44, 95% CI = -4.80 to -0.08). Subgroup analyses indicated that EA may have more of a benefit in the pre-menopausal state (hot flushes score/24 h: MD = -1.66, 95% CI = -3.49 to 0.17) compared to post-menopause (p > 0.05). CONCLUSION: The effect of EA appeared broadly similar to HT and MA in the treatment of PMS, although EA-associated reductions in KI were superior to MA and sham EA, suggesting effects beyond placebo. The evidence base is limited by a small number of eligible studies, risk of bias and clinical/statistical heterogeneity, limiting our ability to draw firm conclusions. As such, additional larger scale, high-quality RCTs are needed.
引用
- Zhong Z, Dong H, Wang H, et al. Electroacupuncture for the treatment of perimenopausal syndrome: a systematic review and meta-analysis of randomized controlled trials. Acupunct Med. 2021. PMID: 34753328. doi:10.1177/09645284211055742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。